A detailed history of 180 Wealth Advisors, LLC transactions in Mannkind Corp stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 2,034,134 shares of MNKD stock, worth $12.1 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
2,034,134
Previous 1,942,210 4.73%
Holding current value
$12.1 Million
Previous $8.8 Million 20.69%
% of portfolio
1.79%
Previous 1.59%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$4.05 - $5.43 $372,292 - $499,147
91,924 Added 4.73%
2,034,134 $10.6 Million
Q1 2024

Apr 15, 2024

BUY
$3.25 - $5.27 $704,860 - $1.14 Million
216,880 Added 12.57%
1,942,210 $8.8 Million
Q4 2023

Jan 24, 2024

BUY
$3.34 - $4.29 $480,492 - $617,159
143,860 Added 9.1%
1,725,330 $6.28 Million
Q3 2023

Oct 31, 2023

BUY
$3.91 - $5.45 $157,209 - $219,128
40,207 Added 2.61%
1,581,470 $6.53 Million
Q2 2023

Jul 11, 2023

BUY
$3.72 - $4.79 $218,085 - $280,813
58,625 Added 3.95%
1,541,263 $6.27 Million
Q1 2023

Apr 07, 2023

BUY
$3.95 - $5.63 $57,239 - $81,584
14,491 Added 0.99%
1,482,638 $6.08 Million
Q4 2022

Feb 02, 2023

SELL
$3.02 - $5.37 $51,907 - $92,299
-17,188 Reduced 1.16%
1,468,147 $7.74 Million
Q3 2022

Oct 12, 2022

BUY
$2.99 - $4.35 $135,958 - $197,798
45,471 Added 3.16%
1,485,335 $4.59 Million
Q2 2022

Jul 11, 2022

BUY
$2.67 - $4.77 $186,793 - $333,709
69,960 Added 5.11%
1,439,864 $5.73 Million
Q1 2022

Apr 22, 2022

BUY
$2.62 - $4.45 $871,092 - $1.48 Million
332,478 Added 32.05%
1,369,904 $4.88 Million
Q4 2021

Jan 26, 2022

BUY
$4.05 - $5.37 $477,782 - $633,504
117,971 Added 12.83%
1,037,426 $3.93 Million
Q3 2021

Oct 28, 2021

BUY
$3.89 - $5.48 $120,321 - $169,501
30,931 Added 3.48%
919,455 $4.68 Million
Q2 2021

Aug 13, 2021

BUY
$3.61 - $5.45 $480,422 - $725,291
133,081 Added 17.62%
888,524 $3.46 Million
Q1 2021

May 25, 2021

BUY
$3.14 - $6.14 $428,352 - $837,606
136,418 Added 22.04%
755,443 $3.2 Million
Q4 2020

Jan 27, 2021

BUY
$1.79 - $4.04 $213,964 - $482,913
119,533 Added 23.93%
619,025 $1.99 Million
Q3 2020

Oct 23, 2020

BUY
$1.56 - $2.08 $33,554 - $44,738
21,509 Added 4.5%
499,492 $1 Million
Q2 2020

Jul 21, 2020

BUY
$0.94 - $2.21 $39,632 - $93,178
42,162 Added 9.67%
477,983 $820,000
Q1 2020

Apr 09, 2020

BUY
$0.84 - $1.76 $34,896 - $73,117
41,544 Added 10.54%
435,821 $411,000
Q4 2019

Jan 17, 2020

BUY
$1.14 - $1.49 $67,830 - $88,655
59,500 Added 17.77%
394,277 $599,000
Q3 2019

Oct 22, 2019

BUY
$1.04 - $1.44 $25,930 - $35,903
24,933 Added 8.05%
334,777 $429,000
Q2 2019

Aug 05, 2019

BUY
$1.09 - $1.88 $63,247 - $109,087
58,025 Added 23.04%
309,844 $363,000
Q1 2019

May 14, 2019

BUY
$1.14 - $2.25 $140,975 - $278,241
123,663 Added 96.49%
251,819 $365,000
Q3 2018

Nov 14, 2018

BUY
$1.01 - $2.19 $40,088 - $86,925
39,692 Added 44.87%
128,156 $235,000
Q2 2018

Aug 08, 2018

BUY
$1.59 - $2.38 $49,471 - $74,051
31,114 Added 54.25%
88,464 $168,000
Q1 2018

Jun 01, 2018

BUY
$2.28 - $3.8 $33,630 - $56,050
14,750 Added 34.62%
57,350 $130,000
Q4 2017

Feb 13, 2018

BUY
$2.28 - $6.71 $97,127 - $285,846
42,600
42,600 $99,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.53B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track 180 Wealth Advisors, LLC Portfolio

Follow 180 Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.